Thane Wettig - Jan 9, 2025 Form 4 Insider Report for FIBROGEN INC (FGEN)

Role
CEO, Director
Signature
/s/ Michael Hom, Attorney-in-Fact
Stock symbol
FGEN
Transactions as of
Jan 9, 2025
Transactions value $
$0
Form type
4
Date filed
1/10/2025, 06:15 PM
Previous filing
Dec 9, 2024
Next filing
Mar 7, 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FGEN Stock Option (Right to Buy) Award $0 +1.3M $0.00 1.3M Jan 9, 2025 Common Stock 1.3M $0.65 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests in equal amount quarterly over 4 years measured from 1/9/2025.